False detection of rifampicin resistance using Xpert® MTB/RIF Ultra assay due to an A451V mutation in <i>Mycobacterium tuberculosis</i>
Margaret Fitzgibbon(Trinity College Dublin), Thomas R. Rogers(Scripps Research Institute), Elaine Brabazon(Institute of Public Health), A -Louise Seagar(National Library of Scotland), Anne-Marie Mc Laughlin(Trinity College Dublin), Gerard Sheehan(Mater Misericordiae University Hospital), Mary O’Meara, Joseph Keane(Trinity College), Keith Ian Quintyne(Institute of Public Health), Peter R. Flanagan(Trinity College Dublin), Ian F. Laurenson(NHS Lothian), Emma Roycroft(Trinity College Dublin)
Cited by 12
Related Papers
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
|New England Journal of Medicine|2001|3.7k
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
|The Lancet Infectious Diseases|2021|450
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
|Clinical Infectious Diseases|1997|426